• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成mRNA表达的反卷积:核苷化学改变可翻译性。

Deconvolution of synthetic mRNA expression: Nucleoside chemistry alters translatability.

作者信息

Moradian Hanieh, Schwestka Marko, Roch Toralf, Gossen Manfred

机构信息

Institute of Active Polymers, Helmholtz-Zentrum Hereon Teltow Germany.

Berlin Institute of Health Center for Regenerative Therapies (BCRT) Berlin Germany.

出版信息

Bioeng Transl Med. 2023 Nov 28;9(4):e10622. doi: 10.1002/btm2.10622. eCollection 2024 Jul.

DOI:10.1002/btm2.10622
PMID:39036083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11256140/
Abstract

Recent technological advances in the production of in vitro transcribed messenger RNA (IVT-mRNA) facilitate its clinical use as well as its application in basic research. In this regard, numerous chemical modifications, which are not naturally observed in endogenous mRNA, have been implemented primarily to address the issue of immunogenicity and improve its biological performance. However, recent findings suggested pronounced differences between expression levels of IVT-mRNAs with different nucleoside modifications in transfected cells. Given the multistep process of IVT-mRNA delivery and subsequent intracellular expression, it is unclear which step is influenced by IVT-mRNA chemistry. Here, we deconvolute this process and show that the nucleoside modification does not interfere with complexation of carriers, their physicochemical properties, and extracellular stability, as exemplified by selected modifications. The immediate effect of mRNA chemistry on the efficiency of ribosomal protein synthesis as a contributor to differences in expression was quantified by in vitro cell-free translation. Our results demonstrate that for the nucleoside modifications tested, translatability was the decisive step in determining overall protein production. Also of special importance for future work on rational selection of tailored synthetic mRNA chemistries, our findings set a workflow to identify potentially limiting, modification-dependent steps in the complex delivery process.

摘要

近期体外转录信使核糖核酸(IVT-mRNA)生产技术的进步促进了其在临床及基础研究中的应用。在这方面,人们进行了多种内源性mRNA中未天然存在的化学修饰,主要是为了解决免疫原性问题并改善其生物学性能。然而,最近的研究结果表明,在转染细胞中,具有不同核苷修饰的IVT-mRNA的表达水平存在显著差异。鉴于IVT-mRNA递送及随后细胞内表达的多步骤过程,尚不清楚IVT-mRNA化学修饰影响的是哪个步骤。在此,我们对这一过程进行了剖析,结果表明,如所选修饰所示,核苷修饰不会干扰载体的复合、其理化性质及细胞外稳定性。通过体外无细胞翻译对作为表达差异原因的mRNA化学修饰对核糖体蛋白合成效率的直接影响进行了量化。我们的结果表明,对于所测试的核苷修饰,可翻译性是决定总体蛋白产量的决定性步骤。我们的研究结果还为合理选择定制化合成mRNA化学修饰的未来工作设定了一个工作流程,以识别复杂递送过程中潜在的、依赖修饰的限制步骤,这对未来工作也尤为重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11256140/9ccbaf35ddff/BTM2-9-e10622-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11256140/f10009933215/BTM2-9-e10622-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11256140/16c3f9cdb41e/BTM2-9-e10622-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11256140/4657ac0fff4e/BTM2-9-e10622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11256140/9ccbaf35ddff/BTM2-9-e10622-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11256140/f10009933215/BTM2-9-e10622-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11256140/16c3f9cdb41e/BTM2-9-e10622-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11256140/4657ac0fff4e/BTM2-9-e10622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11256140/9ccbaf35ddff/BTM2-9-e10622-g004.jpg

相似文献

1
Deconvolution of synthetic mRNA expression: Nucleoside chemistry alters translatability.合成mRNA表达的反卷积:核苷化学改变可翻译性。
Bioeng Transl Med. 2023 Nov 28;9(4):e10622. doi: 10.1002/btm2.10622. eCollection 2024 Jul.
2
Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages.尿苷的化学修饰可调节原代人巨噬细胞中mRNA介导的促炎和抗病毒反应。
Mol Ther Nucleic Acids. 2022 Jan 10;27:854-869. doi: 10.1016/j.omtn.2022.01.004. eCollection 2022 Mar 8.
3
Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.线性化模板质粒DNA的纯化可减少体外转录反应期间双链RNA的形成。
Front Mol Biosci. 2023 Sep 29;10:1248511. doi: 10.3389/fmolb.2023.1248511. eCollection 2023.
4
Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA.用于定量体外转录mRNA加帽效率的核酶分析
Pharmaceutics. 2022 Jan 29;14(2):328. doi: 10.3390/pharmaceutics14020328.
5
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA.一种从体外转录的mRNA中去除双链RNA污染物的简便方法。
Mol Ther Nucleic Acids. 2019 Apr 15;15:26-35. doi: 10.1016/j.omtn.2019.02.018. Epub 2019 Feb 27.
6
Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine.合成 mRNA 的出现:mRNA 的体外合成及其在再生医学中的应用。
Biomaterials. 2018 Feb;156:172-193. doi: 10.1016/j.biomaterials.2017.11.034. Epub 2017 Nov 23.
7
Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.简要综述:体外转录信使核糖核酸在细胞工程与重编程中的应用:进展与挑战
Stem Cells. 2017 Jan;35(1):68-79. doi: 10.1002/stem.2402. Epub 2016 Jun 20.
8
Co-delivery of NS1 and BMP2 mRNAs to murine pluripotent stem cells leads to enhanced BMP-2 expression and osteogenic differentiation.将 NS1 和 BMP2 mRNAs 共递送至鼠多能干细胞可增强 BMP-2 表达和骨向分化。
Acta Biomater. 2020 May;108:337-346. doi: 10.1016/j.actbio.2020.03.045. Epub 2020 Apr 3.
9
Immuno-engineered mRNA combined with cell adhesive niche for synergistic modulation of the MSC secretome.免疫工程化 mRNA 与细胞黏附龛协同调节 MSC 分泌组。
Biomaterials. 2023 Mar;294:121971. doi: 10.1016/j.biomaterials.2022.121971. Epub 2022 Dec 26.
10
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.基于非病毒载体的递药系统的 mRNA 治疗药物递送中的纳米技术。
Gene Ther. 2017 Mar;24(3):133-143. doi: 10.1038/gt.2017.5. Epub 2017 Jan 17.

本文引用的文献

1
LINE1-Mediated Reverse Transcription and Genomic Integration of SARS-CoV-2 mRNA Detected in Virus-Infected but Not in Viral mRNA-Transfected Cells.LINE1 介导的 SARS-CoV-2 mRNA 的逆转录和基因组整合可在病毒感染细胞中检测到,但在病毒 mRNA 转染细胞中未检测到。
Viruses. 2023 Feb 25;15(3):629. doi: 10.3390/v15030629.
2
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line.辉瑞生物科技公司新冠mRNA疫苗BNT162b2在人肝细胞系中的体外细胞内逆转录
Curr Issues Mol Biol. 2022 Feb 25;44(3):1115-1126. doi: 10.3390/cimb44030073.
3
Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages.
尿苷的化学修饰可调节原代人巨噬细胞中mRNA介导的促炎和抗病毒反应。
Mol Ther Nucleic Acids. 2022 Jan 10;27:854-869. doi: 10.1016/j.omtn.2022.01.004. eCollection 2022 Mar 8.
4
Membrane-dependent relief of translation elongation arrest on pseudouridine- and N1-methyl-pseudouridine-modified mRNAs.基于膜的翻译延伸阻滞解除在假尿嘧啶核苷和 N1-甲基假尿嘧啶核苷修饰的 mRNAs 上。
Nucleic Acids Res. 2022 Jul 22;50(13):7202-7215. doi: 10.1093/nar/gkab1241.
5
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery.脂质纳米颗粒化学决定了核苷碱基修饰如何改变 mRNA 的递送。
J Control Release. 2022 Jan;341:206-214. doi: 10.1016/j.jconrel.2021.11.022. Epub 2021 Nov 18.
6
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships.通过逆转录转座子将 SARS-CoV-2 RNA 整合到受感染的人类细胞中:一个不太可能的假设和古老的病毒关系。
Retrovirology. 2021 Oct 29;18(1):34. doi: 10.1186/s12977-021-00578-w.
7
No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues.没有证据表明患者组织中嵌合转录本的起源是SARS-CoV-2逆转录和整合。
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33). doi: 10.1073/pnas.2109066118.
8
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.经逆转录的 SARS-CoV-2 RNA 可整合到培养的人类细胞基因组中,并可在源自患者的组织中表达。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2105968118.
9
The Limitless Future of RNA Therapeutics.RNA疗法的无限未来。
Front Bioeng Biotechnol. 2021 Mar 18;9:628137. doi: 10.3389/fbioe.2021.628137. eCollection 2021.
10
Advancements in mRNA Encoded Antibodies for Passive Immunotherapy.用于被动免疫疗法的mRNA编码抗体的进展
Vaccines (Basel). 2021 Jan 31;9(2):108. doi: 10.3390/vaccines9020108.